Armed... I sent you a note about a week ago... with 3 pics of my daughter. Did you not get that? If not... send me a another note to those old email addresses. I will get one and send another return note to you.
Interesting indeed, especially when this newly approved chemotherapy drug known as Folotyn is NOT very effective.
Here are a few salient points of the article:
"A newly approved chemotherapy drug will cost about $30,000 a month, a sign that the prices of cancer medicines are continuing to rise despite growing concern about health care costs."
"Folotyn has not yet shown an effect on longevity. In the clinical trial that led to approval of the drug, 27 percent of the 109 patients experienced a reduction in tumor size. The reductions lasted a median of 9.4 months.
But considering all the patients in the trial, only 12 percent had a reduction in tumor size that lasted for more than 14 weeks. "
"“This drug is not a home run,” Dr. Brad S. Kahl, a lymphoma specialist at the University of Wisconsin, said during a meeting of an advisory committee to the F.D.A. on Sept. 2. “It’s not even a double. It’s a single.” "
"Patient advocacy groups say that while they wish prices were lower, high prices might be needed to encourage companies to develop new drugs."